Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
74.13
+0.68 (0.93%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Cytokinetics Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Cytokinetics stock has a consensus rating of "Buy" and an average price target of $109.9. The average 1-year stock price forecast is 48.25% higher than the current stock price, while the lowest is $85 (+14.66%) and the highest is $146 (+96.95%).
Price Target: $109.9 (+48.25%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cytokinetics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 11 | 12 | 13 | 13 | 13 |
| Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Hold | 3 | 3 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 21 | 22 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $95 → $110 | Buy | Maintains | $95 → $110 | +48.39% | Aug 14, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $85 | Hold | Maintains | $85 | +14.66% | Aug 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $140 | Buy | Reiterates | $140 | +88.86% | Aug 13, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $97 → $103 | Buy | Reiterates | $97 → $103 | +38.95% | Aug 13, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $112 | Buy | Maintains | $112 | +51.09% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
150.11M
from 88.04M
Increased by 70.50%
Revenue Next Year
422.54M
from 150.11M
Increased by 181.49%
EPS This Year
-5.95
from -6.54
EPS Next Year
-4.44
from -5.95
EPS and Forward PE are based on non-GAAP adjusted numbers.